Jennison Associates
LAB icon

Jennison Associates’s Standard BioTools LAB Stock Holding History

Jennison Associates’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-500,000
Closed -$5.41M – 642
2015
Q4 		$5.41M Hold
500,000
– – 0.01% 517
2015
Q3 		$4.05M Buy
+500,000
New +$7.87M ﹤0.01% 551

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jennison Associates's LAB Position: Q3 2021 in Review

Jennison Associates sold out of Standard BioTools (LAB) in Q3 2021, closing a stake of 134,757 shares — an estimated $830K sold.

Jennison Associates first reported a position in LAB in Q2 2013 and held it in 19 quarters. The position peaked at $133M in Q1 2014. 119 funds tracked by Wall St. Rank hold LAB as of Q3 2021.

  • Jennison Associates reported no remaining Standard BioTools position as of Q3 2021 after selling out during the quarter.
  • Jennison Associates sold 134,757 Standard BioTools shares in Q3 2021, an estimated $830K.
  • Jennison Associates first reported a position in Standard BioTools in Q2 2013 and held it in 19 quarters.
  • Jennison Associates's Standard BioTools position peaked at $133M in Q1 2014.
  • 119 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2021.

Based on Jennison Associates's 13F filing for Q3 2021, filed 9 Nov 2021.